Growth comprises three separate componcnts; whole-body growth, tissue turnover and repair, and last, the response to external stimuli. Whole-body growth can be divided into changes associated with muscle, skin, viscera and skeleton. Because of our interest in bone metabolism the present review will concentratc on the processes associated with skeletal growth, turnover, and response to external stimuli. Although some of the factors which will be discussed are specific to bone the majority affect other body tissues.
Local L O U G I T U D I N A L B O N E G R O W T H
The characteristic histological features of the long bones are developmentally regulated. At birth the columnar structure of the epiphyseal growth plate is incompletely formed.
As a laminar organization of chondrocytes develops in the distal direction (Sissons, 1961) there is a uniformly distributed cell layer consisting of cells which rarely divide (Kember, 1978) . which is termed the germinal layer. During longitudinal growth these cells differentiate and enter the proliferative layer where the cells multiply before maturing into hypertrophic chondrocytes. These cells produce the cartilaginous matrix which subsequently becomes calcified before being resorbed and replaced by osteoblastmediated bone formation (Isaksson et al. 1987) . Thus, longitudinal growth results from the increased production of cells and their subsequent expansion. Post-natal longitudinal bone growth is primarily dependent on GH. but while effects of G H are easily recognized, the site and cellular mechanisms behind these effects are unclear. Salmon & Daughaday (1957) postulated that response to GH was mediated through the hepatic production of somatomedins, now termed insulin-like growth factors (IGF). This is based on the fact that addition of GH to explanted cartilage fragments produces little effect on metabolism. However, addition of serum stimulated a number o f cellular functions associated with proliferation and differentiation. Serum from hypophysectomized animals had a lesser effect but subsequent G H therapy resulted in a serum with normal growth-promoting activities. The structure of both IGF has been elucidated (Rinderknecht & Humbel, 1978~l.h ) and the genes encoding these f. cictors characterized (Jansen et al. 1983 (Jansen et al. . 1985 .
However, Schoenle et al. (1982) infused high doses of purified IGF-1 into hypophysectomized rats but could only induce a slight increase in bone growth which was of a similar magnitude to that induced by GH alone. Similarly, in a study using recombinant IGF-1. high doses had t o be used to induce bone growth, while GH was more effective at a fiftyfold lower dosc (Skottner et af. 1987 ). I t is now apparent that while administration of large doses of IGF-1 significantly increases body-weight, it produces only small effects on longitudinal bone growth.
To examine the possibility that GH might have a direct cffect on the growth plate, Isaksson and colleagues (Isaksson et al. 1982 (Isaksson et al. : lsgaard et al. 1986 Nilsson et al. 1987) infused low concentrations of GH (50 ng/d) directly into the growth plate or into the knee joint and showed that it stimulated longitudinal growth compared with the contralateral limb. IGF-1 was also capable of stimulating epiphyscal cartilage width but a combination of thc two growth promoters produced no additional increase in bone growth. Other groups have confirmed much of this work (Russell & Spencer, 1985; Schlectcr ef al. 1986 ).
These studies have been supportcd by the findings that many tissues produce IGF-1 (D'Ercole et af. 1984) and has led to the development of an alternative concept of GH action whcreby GH has a direct effect on peripheral tissues which in turn mediate the effect by the local production of IGF-1 (Underwood et al. 1986 ). Many o f the organ-specific growth mediators outlined in Table 1 have been shown to stimulate the local production of IGF-1 and IGF-1 may in turn potentiate the response to those growth mediators (for review, see Holly & Wass. 1989). One of the important questions for future research is whether the direct or indirect actions of GH on peripheral tissues are physiological and what is the relative contribution of each pathway to the final cffect.
B I N D I N G P R O T E I N S
Both GH and IGF are either found free or complexed to binding proteins within the circulation. Human plasma is known to contain at least two binding proteins (>lo0 K and 80-85 K) for growth hormone each with varying degrees of affinity for human GH (Baumann et al. 1986; Herington et al. 1986 ). The high affinity peak (80-8s K) is responsible for 80-90% of the complexed GH (Baumann el al. 1989) . Under physiological conditions approximatcly 50% and 29% of the circulating 22 K and 20 K human G H respectively are in a complexed form (Baumann et al. 1988) . At GH concentrations grcater than about 20 ng/ml thc complexed fraction declines in a concentration dependent manner due to partial saturation of the binding protein (Baumann et al. 1988) .
The concentrations of both binding proteins vary considerably from subject to subject in health and disease but are grossly maintained within the normal rangc in a number of diverse conditions which are known to result in abnormal GH levels such as acute infection, liver cirrhosis. acromegaly. uraemia (Baumann et al. 1989) . The levels of binding protein were, however, significantly lower in neonates but reached the adult levels by 1 year of age (Baumann et al. 1989) . Limited evidence exists that thc two binding proteins are differentially regulated with the larger binding protein (> 100 K) having sex hormone dependency but not thc high-affinity binding protein (80-85 K).
More than 98% of plasma IGF-1 and IGF-2 is bound to a 150 K complex whose concentration is GH dependent . Acidification results in an acid-stable subunit of 50 K with a binding sitc with equal high affinity for either IGF-I or IGF-2 .
A group of smaller binding proteins (25-43 K) are also present in serum and one of these (26 K) is found in amniotic fluid (Povoa el al. 1984) . The serum levels of this protein are low in acromegaly and raised in hypopituitarism so it is believed to be
inversely related to G H (Drop et al. 1984) . Injection of GH to GH-deficient patients resulted in a fall in the level of binding protein (Busby cf al. 1988) , although it has been reported that the levels rise during the nocturnal increase in G H secretion (Baxtcr & Colwcll, 1087) . Studies on nutritional influences on this protein have shown that its concentration falls after a meal (Baxter & Colwell, 1987; Busby et al. 1988 ) and rises during overnight fasting (Busby et nl. 1988) and during the infusion of glucose and insulin (Sukkari et al. 1988) .
As the IGF-and GH-binding proteins have only recently been characterized the role of such binding proteins in thc expression of the biological activity of these growth promoters is as yet unclear. One function that has been attributed t o them is to protect GH (Baumann et ul. 1987) The presence of these binding proteins has undoubtedly important implications in the mctabolism. distribution and physiological activity of G H and the IGFs but these processes are as yet unclear and warrant further research.
LOCAL. T U R N O V E R AND R E P A I R
The activity of osteoblasts and osteoclasts is closely coupled (Rodan & Martin, 1981) which results in skeletal turnover without accretion or loss. Both the activity and the proliferation and differentiation of bone cells appear to be under the control of a number of growth factors. The bone matrix itself is a storehouse for a plethora of factors which can induce bone formation. In thc 1960s, Marshall Urist (1965) showed that devitalized bone was capable of inducing cndochondral bone formation. Several groups have pursued this line of research and have purified a number of growth factors (Reddi & Anderson, 1976) .
In addition to these bone spccitic growth factors there are othcr growth factors which have a more general activity and arc also found within the bone matrix. These include IGF-2 (Mohan et al. 1988) , fibroblast growth factor (Hauschka et af. 1986) which is mitogenic for mesoderm-and neuroectoderm-derived cclls (Gospodarowicz et al. 1987) and TGF-P (Sporn et ul. 1987) .
Work in our laboratory is concerned with two aspects of the control of bone cell activity. First the development of novel techniques which enable the in sitri measurement of the biochemistry of bone cells (Bradbeer et al. 1988; Loveridge & Farquharson, 1989) , and second the purification of a factor relcascd from osteoblasts which stimulates the proliferation and differentiation of osteoclasts (Dickson & Scheven, 1983; Scheven et af. 1989) . This factor affects the number of osteoclasts but not the activity of existing osteoclasts and has been termed osteoclast growth factor (OGF). TGF-P is produced by osteoblasts in response to calciotropic hormones and inhibits bone resorption induced by other factors (Pfeilschifter et al. 1988) . although in some systems it stimulates bone resorption (Tashjian et al. 1985) . TGF-P is produced as a latent precursor molecule which is then cleaved t o release the biologically active TGF-P (Sporn et al. 1987) . a process of which the osteoclast is capable (Oreffo et al. 1989) . In some but not all in vitro assays TGF-P stimulates markers of bone formation such as osteoblastic alkaline phosphatase (EC 3.1.3.1) activity (Pfcilschiftcr ef al. 1987) . Thus, it has been suggested that TGF-P acts as an anabolic coupling factor by stimulating formation and inhibiting rcsorption. In our laboratory, however, while TGF-P inhibits osteoclastic activity it also inhibits osteoblastic activity (Loveridge & Farquharson, 1989) , although the latter action is about 100 times less sensitive.
R E S P O N S E T O E X T E R N A L S T I M U L I
The last aspect of growth which we will discuss is the response to external stimuli. In the case of bone it is obvious that external stimuli such as dietary deficiencies of vitamin D, changes in the availability of Ca or increased demand for Ca result in alterations in the Ca homeostatic mechanisms with a consequent loss of skcletal material. Similarly metabolic diseases such as diabetes can result in significant bone loss (Hui et al. 1985) . What is less well characterized is the response to mechanical stress.
It is well known that the capacity of bone to remodel itself is influenced by the degrcc of mechanical loading. For instance, prolonged bed rest results in disuse ostcoporosis (Asher, 1947; Krolner & Toft, 1983) . Furthermore, short periods of mechanical stress in which the magnitude and distributior. of the dynamic strains within the bone are different from those to which it is normally accustomed (Lanyon, 1984) result in profound changes in remodelling activity.
What is not clear at present is the mechanism of response to loading, although recent evidence suggests a possible role for the osteocyte (Pead et al. 1988 ).
S U M M A R Y
In the present review it is not possible to discuss thc cffccts of the numerous endogcnous mediators of growth. What we have attempted to do is to indicate the areas of controversy and the need for further rcscarch. In our view, four main questions arise. First, what are the relative contributions of the direct and indirect effects of GH? Indeed. if GH can produce all its effects by local production of IGF, is the original somatomedin hypothesis still tenable'? Second, how is the biological activity of the 1GF modified by the presence of binding proteins? Because of the role of binding proteins in modulating IGF bioactivity, care must be taken when interpreting results from immunoassays for IGF because this will only represent the concentration of IGF not the level of biological activity, a situation which is analogous to that which pertains with certain polypeptide hormones (for review, see Robertson et al. 1987) . Third, how are the activitics of the osteoblast and osteoclast coupled so that in the mature adult, bone formation and bone resorption are roughly equivalent? Understanding of this process will undoubtedly involve the elucidation of the roles arid interactions between a number of locally acting growth factors and systemic hormones and will lead to the understanding of certain metabolic bone diseases such as osteoporosis. Last, how is the response to local stimuli such as mechanical stress transduced? This is again probably dependent on the activity of local growth factors but may also involve changes in the interactions between bone cells and their underlying matrix components (Skerry et al. 1988) .
